Disclosed is a hydroalcoholic gel pharmaceutical composition comprising: i. from 1.50 percent to 1.70 percent (w/w) testosterone； ii. from 0.6 percent to 1.2 percent (w/w) isopropyl myristate； iii. from 60 percent to 80 percent (w/w) of an alcohol selected from the group consisting of ethanol and isopropanol； iv. a sufficient amount of a thickening agent to give the composition a viscosity in excess of 9000 cps, said thickening agent being formed by combining a precursor polyacrylic acid with a neutralizer in the course of forming the composition； and v. water. Also disclosed is the use of testosterone for manufacturing the composition.
